3 Futurists Predict AI, Biotech and Space Will Reshape America Over 250 Years
Updated
Updated · CBS New York · Jul 2
3 Futurists Predict AI, Biotech and Space Will Reshape America Over 250 Years
3 articles · Updated · CBS New York · Jul 2
Summary
Three futurists told CBS News the United States' next 250 years will be defined by artificial intelligence, engineered biology and a contest for control of low-Earth orbit.
Amy Webb said biology has crossed a threshold into an engineering discipline, pointing to a COVID-19 vaccine sequence designed in about two days and envisioning genome-tailored therapies and software-like drug and food production.
Brian David Johnson said the falling barrier between digital systems and biology could transform daily life, while AI will force a revaluation of human labor rather than simply repeat past industrial shifts.
George Friedman argued the satellite buildout already has military consequences, citing the Ukraine war as evidence that intelligence from low-Earth orbit now shapes targeting and raises the question of who controls space.
Set against Benjamin Franklin's 1780 future-gazing letter and a U.S. time capsule sealed until 2276, the forecasts frame America's challenge as planning beyond leaders' usual 18-24 month horizon.
Amidst 2026 federal funding freezes, how can America sustain its scientific leadership and prevent a brain drain?
Will AI create more jobs than it destroys, or is the belief that humans always adapt a dangerous myth?
As private firms and new nations join the space race, who will write the rules for controlling low-Earth orbit?
The Tipping Point: How AI, Biotechnology, and Space Are Reshaping America’s Economy, Security, and Identity
Overview
The report highlights that the world is at a critical turning point, driven by rapidly accelerating technological changes and growing competition between the United States and China. The U.S. faces significant challenges, including weaknesses in its manufacturing and supply chains, and must also manage the societal and environmental impacts of new technologies like AI. This situation calls for a strategic re-evaluation, especially as China’s advantage in biotechnology comes from lower development costs for scientists. To stay competitive, the U.S. needs to address its own cost structures and adapt to these fast-moving changes.